Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS??? EQUITY

v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022 [1]   10,750,586      
Beginning balance at Dec. 31, 2022 $ 247,077 $ 129 $ 460,660 $ (45,185) $ (168,527)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity-based compensation 1,936   1,936    
Issuance of common stock under employee equity plans, net of shares withheld (in shares) [1]   6,882      
Issuance of common stock under employee equity plans, net of shares withheld (43)   (43)    
Cumulative translation adjustment (3,925)     (3,925)  
Net loss (9,553)       (9,553)
Ending balance (in shares) at Mar. 31, 2023 [1]   10,757,468      
Ending balance at Mar. 31, 2023 $ 235,492 $ 129 462,553 (49,110) (178,080)
Beginning balance (in shares) at Dec. 31, 2023 10,567,881 10,567,881 [1]      
Beginning balance at Dec. 31, 2023 $ 148,618 $ 128 466,172 (50,269) (267,413)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity-based compensation 1,956   1,956    
Issuance of common stock under employee equity plans, net of shares withheld (in shares) [1]   19,458      
Issuance of common stock under employee equity plans, net of shares withheld $ (88)   (88)    
Repurchase of shares (in shares) (113,959) (104,103)      
Repurchase of shares $ (1,063)   (1,063)    
Cumulative translation adjustment (4,980)     (4,980)  
Net loss $ (8,933)       (8,933)
Ending balance (in shares) at Mar. 31, 2024 10,483,236 10,483,236 [1]      
Ending balance at Mar. 31, 2024 $ 135,510 $ 128 $ 466,977 $ (55,249) $ (276,346)
[1] Adjusted for the one-for-12 Reverse Stock Split. Refer to Note 13, “Stockholders’ Equity.”